Curriculum Vitaes

yamada harumoto

  (山田 治基)

Profile Information

Affiliation
School of Medicine, Faculty of Medicine, Fujita Health University
Degree
博士(医学)(慶應義塾大学)

J-GLOBAL ID
200901009942077470
researchmap Member ID
1000289390

Misc.

 152
  • Daiki Ikeda, Hiroshi Ageta, Kunihiro Tsuchida, Harumoto Yamada
    BIOMARKERS, 18(7) 565-572, Nov, 2013  
    Objective: We performed comprehensive proteomic analyses of articular cartilage by using the isobaric tags for relative and absolute quantitation (iTRAQ) method, and searched for candidate biomarkers for osteoarthritis (OA). Methods: Articular cartilage was collected from patients with OA or femoral neck fracture for the control group. Molecular variations were detected by the iTRAQ method, and quantitative analyses were performed by western blot. Results: Using the iTRAQ method, we identified 76 proteins with different expression levels in OA patients and the control group. Among these proteins, we selected LECT2 (leukocyte cell-derived chemotaxin-2), BAALC (brain and acute leukemia, cytoplasmic), and PRDX6 (peroxiredoxin-6), which had not been reported as biomarkers for OA. Conclusions: Use of these proteins in combination with conventional OA biomarkers may better reflect the grade and prognosis of OA.
  • Daiki Ikeda, Hiroshi Ageta, Kunihiro Tsuchida, Harumoto Yamada
    BIOMARKERS, 18(7) 565-572, Nov, 2013  
    Objective: We performed comprehensive proteomic analyses of articular cartilage by using the isobaric tags for relative and absolute quantitation (iTRAQ) method, and searched for candidate biomarkers for osteoarthritis (OA). Methods: Articular cartilage was collected from patients with OA or femoral neck fracture for the control group. Molecular variations were detected by the iTRAQ method, and quantitative analyses were performed by western blot. Results: Using the iTRAQ method, we identified 76 proteins with different expression levels in OA patients and the control group. Among these proteins, we selected LECT2 (leukocyte cell-derived chemotaxin-2), BAALC (brain and acute leukemia, cytoplasmic), and PRDX6 (peroxiredoxin-6), which had not been reported as biomarkers for OA. Conclusions: Use of these proteins in combination with conventional OA biomarkers may better reflect the grade and prognosis of OA.
  • 山田治基
    【健康・栄養科学シリーズ】人体の構造と機能及び疾病の成り立ち 各論 改訂第2版, Sep, 2013  
  • Makoto Nishio, Arihiko Kanaji, Keisuke Horiuchi, Atsushi Funayama, Teruyo Oishi, Yoshiaki Toyama, Harumoto Yamada
    Current Orthopaedic Practice, 24(5) 552-556, Sep, 2013  
  • 大石央代, 金治有彦, 早川和恵, 前原一之, 山田治基
    中部整災誌, 56(1) 118-118, Sep, 2013  
  • Makoto Nishio, Arihiko Kanaji, Keisuke Horiuchi, Atsushi Funayama, Teruyo Oishi, Yoshiaki Toyama, Harumoto Yamada
    Current Orthopaedic Practice, 24(5) 552-556, Sep, 2013  
  • Hideki Date, Syunzo Thujimura, Harumoto Yamada, Kenji Nakagawa
    Knee 2013, Jul(18), Jun, 2013  
  • Hideki Date, Syunzo Thujimura, Harumoto Yamada, Kenji Nakagawa
    Knee 2013, Jul(18), Jun, 2013  
  • 山田治基, 伊達秀樹, 辻村俊造, 早川和恵, 森田充浩
    THE BONE, 27(1) 63-70, Mar, 2013  
  • 山田治基, 伊達秀樹, 辻村俊造, 早川和恵, 森田充浩
    THE BONE, 27(1) 63-70, Mar, 2013  
  • Teruyo Oishi, Akiyoshi Uezumi, Arihiko Kanaji, Naoki Yamamoto, Asami Yamaguchi, Harumoto Yamada, Kunihiro Tsuchida
    PLOS ONE, 8(2), Feb, 2013  
    Heterotopic ossification (HO) is defined as the formation of ectopic bone in soft tissue outside the skeletal tissue. HO is thought to result from aberrant differentiation of osteogenic progenitors within skeletal muscle. However, the precise origin of HO is still unclear. Skeletal muscle contains two kinds of progenitor cells, myogenic progenitors and mesenchymal progenitors. Myogenic and mesenchymal progenitors in human skeletal muscle can be identified as CD56(+) and PDGFR alpha(+) cells, respectively. The purpose of this study was to investigate the osteogenic differentiation potential of human skeletal muscle-derived progenitors. Both CD56(+) cells and PDGFR alpha(+) cells showed comparable osteogenic differentiation potential in vitro. However, in an in vivo ectopic bone formation model, PDGFR alpha(+) cells formed bone-like tissue and showed successful engraftment, while CD56(+) cells did not form bone-like tissue and did not adapt to an osteogenic environment. Immunohistological analysis of human HO sample revealed that many PDGFR alpha(+) cells were localized in proximity to ectopic bone formed in skeletal muscle. MicroRNAs (miRNAs) are known to regulate many biological processes including osteogenic differentiation. We investigated the participation of miRNAs in the osteogenic differentiation of PDGFR alpha(+) cells by using microarray. We identified miRNAs that had not been known to be involved in osteogenesis but showed dramatic changes during osteogenic differentiation of PDGFR alpha(+) cells. Upregulation of miR-146b-5p and -424 and downregulation of miR-7 during osteogenic differentiation of PDGFR alpha(+) cells were confirmed by quantitative real-time RT-PCR. Inhibition of upregulated miRNAs, miR-146b-5p and -424, resulted in the suppression of osteocyte maturation, suggesting that these two miRNAs have the positive role in the osteogenesis of PDGFR alpha(+) cells. Our results suggest that PDGFR alpha(+) cells may be the major source of HO and that the newly identified miRNAs may regulate osteogenic differentiation process of PDGFR alpha(+) cells.
  • Teruyo Oishi, Akiyoshi Uezumi, Arihiko Kanaji, Naoki Yamamoto, Asami Yamaguchi, Harumoto Yamada, Kunihiro Tsuchida
    PLOS ONE, 8(2), Feb, 2013  
    Heterotopic ossification (HO) is defined as the formation of ectopic bone in soft tissue outside the skeletal tissue. HO is thought to result from aberrant differentiation of osteogenic progenitors within skeletal muscle. However, the precise origin of HO is still unclear. Skeletal muscle contains two kinds of progenitor cells, myogenic progenitors and mesenchymal progenitors. Myogenic and mesenchymal progenitors in human skeletal muscle can be identified as CD56(+) and PDGFR alpha(+) cells, respectively. The purpose of this study was to investigate the osteogenic differentiation potential of human skeletal muscle-derived progenitors. Both CD56(+) cells and PDGFR alpha(+) cells showed comparable osteogenic differentiation potential in vitro. However, in an in vivo ectopic bone formation model, PDGFR alpha(+) cells formed bone-like tissue and showed successful engraftment, while CD56(+) cells did not form bone-like tissue and did not adapt to an osteogenic environment. Immunohistological analysis of human HO sample revealed that many PDGFR alpha(+) cells were localized in proximity to ectopic bone formed in skeletal muscle. MicroRNAs (miRNAs) are known to regulate many biological processes including osteogenic differentiation. We investigated the participation of miRNAs in the osteogenic differentiation of PDGFR alpha(+) cells by using microarray. We identified miRNAs that had not been known to be involved in osteogenesis but showed dramatic changes during osteogenic differentiation of PDGFR alpha(+) cells. Upregulation of miR-146b-5p and -424 and downregulation of miR-7 during osteogenic differentiation of PDGFR alpha(+) cells were confirmed by quantitative real-time RT-PCR. Inhibition of upregulated miRNAs, miR-146b-5p and -424, resulted in the suppression of osteocyte maturation, suggesting that these two miRNAs have the positive role in the osteogenesis of PDGFR alpha(+) cells. Our results suggest that PDGFR alpha(+) cells may be the major source of HO and that the newly identified miRNAs may regulate osteogenic differentiation process of PDGFR alpha(+) cells.
  • Kunihiro Tsuchida, Teruyo Oishi, Akiyoshi Uezumi, Harumoto Yamada
    Human Genet Embryol, 3, 2013  
  • Yasuyoshi Mizutani, Kazuhiro Matsuoka, Hiroyuki Takeda, Ken-ichi Inada, Kazue Hayakawa, Harumoto Yamada, Tatsuhiko Miyazaki, Tatsuya Sawasaki
    J.Immunol Methods, 387(1-2) 57-70, Jan, 2013  
    Synovial tissue in rheumatoid arthritis (RA) shows dense infiltration of plasmacytes. The purpose of the present study is to identify and localize autoantibodies produced in these immunocytes in RA synovitis. We developed a novel screening system for detecting specific autoantigens. Protein antigens recognized by antibodies in the serum and synovial tissue extract from five RA patients were screened with the AlphaScreen method. For screening, a biotinylated human autoantigen library was constructed by the wheat germ cell-free protein synthesis system. The AlphaScreen analysis of 2183 proteins detected a limited number of antigens reactive with the serum and synovial tissue extract. Eighteen biotinylated proteins, containing top five showing high signals in each synovitis tissue extract, were utilized as probes for the enzyme-labeled antigen method, in order to visualize the site of specific antibody production in synovial lesions. Specific antibodies against two proteins, tripartite motif-containing 21 (TRIM21, also known as SSA/Ro52) and F-box only protein 2 (FBXO2), were visualized in the cytoplasm of plasmacytes in two RA synovitis lesions, respectively. Absorption experiments using unlabeled proteins confirmed the specificity of staining. No positive signals against these two proteins were identified in the additionally evaluated RA and osteoarthritis synovial lesions. The present study indicated 1) the usefulness of screening the human autoantigen library with the AlphaScreen assay for detecting autoantibodies in RA synovitis, and 2) the applicability of biotinylated proteins to the enzyme-labeled antigen method for visualizing the site of autoantibody production within the lesion.
  • Hideki Date, Kazue Hayakawa, Harumoto Yamada
    KNEE, 20(1) 58-62, Jan, 2013  
    Diabetes mellitus causes neuromusculoskeletal disorders characterized by abnormalities of nervous tissue, joint and bone. Early diagnosis and prevention of disease progression is difficult in cases of neuropathic arthropathy of the knee in diabetes. We report the case of a patient with type 1 diabetes mellitus who developed an insufficiency fracture of the medial part of the proximal tibia, which was viewed as an early finding of neuropathic arthropathy of the knee. In surgical treatment of the fracture, allograft bone transplantation and internal fixation were performed after curettage of the pathologically fragile lesion. Postoperatively, radiological findings have showed complete allograft bone incorporation and no evidence of degenerative changes. Recognition of an insufficiency fracture of the knee as an early indicator of neuropathic arthropathy and prompt treatment of the fracture using allograft bone transplantation could result in joint preservation. (C) 2012 Elsevier B.V. All rights reserved.
  • Kunihiro Tsuchida, Teruyo Oishi, Akiyoshi Uezumi, Harumoto Yamada
    Human Genet Embryol, 3, 2013  
  • Yasuyoshi Mizutani, Kazuhiro Matsuoka, Hiroyuki Takeda, Ken-ichi Inada, Kazue Hayakawa, Harumoto Yamada, Tatsuhiko Miyazaki, Tatsuya Sawasaki
    J.Immunol Methods, 387(1-2) 57-70, Jan, 2013  
    Synovial tissue in rheumatoid arthritis (RA) shows dense infiltration of plasmacytes. The purpose of the present study is to identify and localize autoantibodies produced in these immunocytes in RA synovitis. We developed a novel screening system for detecting specific autoantigens. Protein antigens recognized by antibodies in the serum and synovial tissue extract from five RA patients were screened with the AlphaScreen method. For screening, a biotinylated human autoantigen library was constructed by the wheat germ cell-free protein synthesis system. The AlphaScreen analysis of 2183 proteins detected a limited number of antigens reactive with the serum and synovial tissue extract. Eighteen biotinylated proteins, containing top five showing high signals in each synovitis tissue extract, were utilized as probes for the enzyme-labeled antigen method, in order to visualize the site of specific antibody production in synovial lesions. Specific antibodies against two proteins, tripartite motif-containing 21 (TRIM21, also known as SSA/Ro52) and F-box only protein 2 (FBXO2), were visualized in the cytoplasm of plasmacytes in two RA synovitis lesions, respectively. Absorption experiments using unlabeled proteins confirmed the specificity of staining. No positive signals against these two proteins were identified in the additionally evaluated RA and osteoarthritis synovial lesions. The present study indicated 1) the usefulness of screening the human autoantigen library with the AlphaScreen assay for detecting autoantibodies in RA synovitis, and 2) the applicability of biotinylated proteins to the enzyme-labeled antigen method for visualizing the site of autoantibody production within the lesion.
  • Hideki Date, Kazue Hayakawa, Harumoto Yamada
    KNEE, 20(1) 58-62, Jan, 2013  
    Diabetes mellitus causes neuromusculoskeletal disorders characterized by abnormalities of nervous tissue, joint and bone. Early diagnosis and prevention of disease progression is difficult in cases of neuropathic arthropathy of the knee in diabetes. We report the case of a patient with type 1 diabetes mellitus who developed an insufficiency fracture of the medial part of the proximal tibia, which was viewed as an early finding of neuropathic arthropathy of the knee. In surgical treatment of the fracture, allograft bone transplantation and internal fixation were performed after curettage of the pathologically fragile lesion. Postoperatively, radiological findings have showed complete allograft bone incorporation and no evidence of degenerative changes. Recognition of an insufficiency fracture of the knee as an early indicator of neuropathic arthropathy and prompt treatment of the fracture using allograft bone transplantation could result in joint preservation. (C) 2012 Elsevier B.V. All rights reserved.
  • Koichi Muramatsu, Yudo Hachiya, Hiroyuki Izawa, Harumoto Yamada
    CELL AND TISSUE BANKING, 13(4) 529-536, Dec, 2012  
    We have selected heat-treated bone allografts as the graft material since the Tokai Bone Bank, the first regional bone bank in Japan, was established in 1992. In this study, we examined changes in bone mineral density (BMD), and morphology observed by magnetic resonance imaging (MRI), and histological findings of bone grafts in cases followed up for 7-10 years after bone grafting to grasp the remodeling of heat-treated cortical bone allografts for posterior lumber interbody fusion (PLIF). BMD of bone grafts was reduced by half at 10 years after grafting. MRI revealed that bone grafts were indistinguishable initially in only 22.2% of cases, whereas after a lengthy period of 10 years distinguishable in many cases. Histologically, new bone formation at the graft-host interface was observed earlier, at 1 year after grafting, than that at the periphery of canals in the specimens. The laminated structure of the cortical bone eroded over time, and fragmented bone trabeculae were observed in the specimens at 8 years or longer after grafting, though necrotic bone still remained in some sites.
  • Koichi Muramatsu, Yudo Hachiya, Hiroyuki Izawa, Harumoto Yamada
    CELL AND TISSUE BANKING, 13(4) 529-536, Dec, 2012  
    We have selected heat-treated bone allografts as the graft material since the Tokai Bone Bank, the first regional bone bank in Japan, was established in 1992. In this study, we examined changes in bone mineral density (BMD), and morphology observed by magnetic resonance imaging (MRI), and histological findings of bone grafts in cases followed up for 7-10 years after bone grafting to grasp the remodeling of heat-treated cortical bone allografts for posterior lumber interbody fusion (PLIF). BMD of bone grafts was reduced by half at 10 years after grafting. MRI revealed that bone grafts were indistinguishable initially in only 22.2% of cases, whereas after a lengthy period of 10 years distinguishable in many cases. Histologically, new bone formation at the graft-host interface was observed earlier, at 1 year after grafting, than that at the periphery of canals in the specimens. The laminated structure of the cortical bone eroded over time, and fragmented bone trabeculae were observed in the specimens at 8 years or longer after grafting, though necrotic bone still remained in some sites.
  • Y. Yamamoto, Y. Washimi, A. Kanaji, K. Tajima, D. Ishimura, H. Yamada
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 35(2) 139-145, Feb, 2012  
    Aim: This study compares the effect of bisphosphonate and intermittent PTH administration on haversian remodeling in cortical bone allografts in rabbits. Materials and methods: An intercalary heat-treated cortical bone allograft was applied to a segment skeletal defect in the left femur of Japanese white rabbits. The rabbits were randomly assigned to one of three groups: the vehicle control group (CNT); the bisphosphonate group (B group); and the intermittent PTH treatment group (P group). Periodic radiographic evaluation was performed and peripheral quantitative computerized tomography (pQCT) was used to evaluate the total bone area (Area), bone mineral density (BMD), and bone mineral content (BMC). The allografts also underwent histological examination. Results: The P group was radiographically superior in the latter stage, compared with the other groups. pQCT analysis of the allografts showed that the B group had a significantly higher Area and BMC. These parameters in the latter stage were significantly lower in the P group than in the other groups. The allograft of the B group was histologically mostly necrotic bone, whereas allograft of the P group showed abundant newly formed bone. Conclusion: In rabbits, bisphosphonate prevents resorption, but suppresses remodeling and incorporation; by contrast, PTH increases resorption and accelerates allograft remodeling and incorporation. Based on our preliminary data, we suggest that further research on the manner of administration of bisphosphonate and PTH - which have contrasting effects can be beneficial in maintaining bone strength and in regulating remodeling and allograft incorporation. (J. Endocrinol. Invest. 35: 139-145, 2012) (C) 2012, Editrice Kurtis
  • Y. Yamamoto, Y. Washimi, A. Kanaji, K. Tajima, D. Ishimura, H. Yamada
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 35(2) 139-145, Feb, 2012  
    Aim: This study compares the effect of bisphosphonate and intermittent PTH administration on haversian remodeling in cortical bone allografts in rabbits. Materials and methods: An intercalary heat-treated cortical bone allograft was applied to a segment skeletal defect in the left femur of Japanese white rabbits. The rabbits were randomly assigned to one of three groups: the vehicle control group (CNT); the bisphosphonate group (B group); and the intermittent PTH treatment group (P group). Periodic radiographic evaluation was performed and peripheral quantitative computerized tomography (pQCT) was used to evaluate the total bone area (Area), bone mineral density (BMD), and bone mineral content (BMC). The allografts also underwent histological examination. Results: The P group was radiographically superior in the latter stage, compared with the other groups. pQCT analysis of the allografts showed that the B group had a significantly higher Area and BMC. These parameters in the latter stage were significantly lower in the P group than in the other groups. The allograft of the B group was histologically mostly necrotic bone, whereas allograft of the P group showed abundant newly formed bone. Conclusion: In rabbits, bisphosphonate prevents resorption, but suppresses remodeling and incorporation; by contrast, PTH increases resorption and accelerates allograft remodeling and incorporation. Based on our preliminary data, we suggest that further research on the manner of administration of bisphosphonate and PTH - which have contrasting effects can be beneficial in maintaining bone strength and in regulating remodeling and allograft incorporation. (J. Endocrinol. Invest. 35: 139-145, 2012) (C) 2012, Editrice Kurtis
  • 森田充浩, 中川雅人, 金治有彦, 田中徹, 山田治基
    日本人工関節学会誌, 42 111-112, 2012  
  • 金治有彦, 中川雅人, 田中徹, 大石央代, 山田治基
    日本人工関節学会誌, 42 339-340, 2012  
  • 金治有彦, 中川雅人, 田中徹, 大石央代, 山田治基
    日本人工関節学会誌, 42 625-626, 2012  
  • 大石央代, 金治有彦, 中川雅人, 田中徹, 山田治基
    日本人工関節学会誌, 42 627-628, 2012  
  • 西尾真, 金治有彦, 中川雅人, 田中徹, 大石央代, 山田治基
    日本人工関節学会誌, 42 635-636, 2012  
  • 大石央代, 金治有彦, 前原一之, 前原秀紀, 中川雅人, 田中徹, 山田治基
    東海関節, 4 91-95, 2012  
  • 金治有彦, 中川雅人, 田中徹, 森田充浩, 大石央代, 山田治基
    日本関節病学会誌, 31(4) 493-497, 2012  
  • 山田治基, 早川和恵, 森田充浩
    日本医師会雑誌, 41(8) 691-695, 2012  
  • MAEHARA Hideki
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(6) 1379-1380, 2012  
  • OISHI Teruyo
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(6) 1381-1382, 2012  
  • KANAJI Arihiko
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(6) 1383-1384, 2012  
  • OISHI Teruyo
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(6) 1431-1432, 2012  
  • 金治有彦, 中川雅人, 田中徹, 森田充浩, 大石央代, 山田治基
    Hip joint, 38 217-220, 2012  
  • 吉岡淳思, 金治有彦, 中川雅人, 田中徹, 森田充浩, 山田治基
    Hip joint, 38 485-487, 2012  
  • 大石央代, 金治有彦, 中川雅人, 田中徹, 森田充浩, 山田治基
    Hip joint, 38 1153-1155, 2012  
  • KANAJI Arihiko
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(4) 725-726, 2012  
  • KANAJI Arihiko
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(4) 811-812, 2012  
  • MORITA Mitsuhiro
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(3) 559-560, 2012  
  • KANAJI Arihiko
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(2) 301-302, 2012  
  • KANAJI Arihiko
    The Central Japan Journal of Orthopaedic Surgery & Traumatology, 55(2) 303-304, 2012  
  • 早川和恵, 伊達秀樹, 辻村俊造, 木村昌芳, 野尻 翔, 冨永 整, 山田治基, 中川研二
    日本人工関節学会誌, 42 223-224, 2012  
  • 辻村俊造, 早川和恵, 伊達秀樹, 木村昌芳, 野尻 翔, 冨永 整, 山田治基, 中川研二
    日本人工関節学会誌, 42 399-400, 2012  
  • 大石央代, 金治有彦, 早川和恵, 前原一之, 山田治基
    中部整災誌, 56(1) 118-118, 2012  
  • 森田充浩, 山田治基
    病気と薬 パーフェクトBook2010, 61(4) 1160-1162, 2012  

Presentations

 153

作成した教科書、教材、参考書

 1
  • 件名(英語)
    -
    終了年月日(英語)
    2013
    概要(英語)
    標準整形外科学 第1版 第7章 関節の病態、病理